Mr. Tyler Robson reports

VALENS GROWORKS RECEIVES $602,200 FROM WARRANT EXERCISE

Valens Groworks Corp. has received $602,200 from the exercise of share purchase warrants. A total of 523,653 warrants were exercised at $1.15 and the company is issuing a total of 523,653 common shares. The warrants were issued in connection with a non-brokered private placement financing in January, 2017, and expired on Jan. 11, 2018.

Tyler Robson, chief executive officer of Valens Groworks, commented: "We are very pleased with the level of support received from our shareholders as demonstrated by the closing of our recent $2-million funding, as well as the exercise of these warrants. With our significantly improved treasury, Valens Groworks is well positioned to advance its corporate initiatives."

About Valens Groworks Corp.

Valens Groworks is Canadian publicly traded biotechnology company executing on its plants to premium products objectives through two wholly owned subsidiaries, located at the company's expanding 17,000-square-foot facility on two acres in Kelowna, in the heart of British Columbia's Okanagan Valley. Subsidiary Valens Agritech (VAL) is commencing cannabis production and sales under a Health Canada dealer's licence, and is also a late-stage licence applicant to cultivate medical marijuana under the ACMPR (Access to Cannabis for Medical Purposes Regulations) for individual patients. Subsidiary Supra THC Services is a Health Canada-licensed cannabis-testing lab providing sector-leading analytical and proprietary services to licensed producers, ACMPR patients and the natural health products industry.

Supra has partnered with Thermo Fisher Scientific to develop a centre of excellence in plant-based medicine analytics in Kelowna, and both subsidiaries are involved in a collaborative research partnership with British Columbia-based universities UBC Okanagan and Thompson Rivers to explore the vast range of bioproducts that can be made from cannabis plant materials.

We seek Safe Harbor.